# A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations

> **NCT04338711** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 23 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** tofacitinib modified release (MR)

## Key facts

- **NCT ID:** NCT04338711
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-17
- **Primary completion:** 2020-09-15
- **Final completion:** 2020-09-15
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2020-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04338711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04338711, "A Study In Adult Healthy Volunteers To Asses Once Daily (QD) Dosing With The Selected Age-Appropriate Modified Release (MR) Formulations". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04338711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*